Brand Name: VANFLYTA. Generic Name: (quizartinib). VANFLYTA (quizartinib) is used to use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria.
VANFLYTA is a kinase inhibitor (a kinase is a type of protein that regulates the function of cells in your body) that is used in combination with certain chemotherapy medicines and alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia (AML) with a specific mutation called FLT3 internal tandem duplication (FLT3-ITD) mutation. VANFLYTA is not indicated for use alone as maintenance therapy following a stem cell transplantation (bone marrow transplant).
Brand Name: | VANFLYTA |
Generic Name: | quizartinib |
Strength: | Tablets: 17.7 mg or 26.5 mg. |
Manufacturer: | Daiichi Sankyo, Inc. |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “VANFLYTA (quizartinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for VANFLYTA (quizartinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.